Vaccinating adolescents against SARS-CoV-2 in England: a risk–benefit analysis

Twitter thread by Deepti Gurdasani

Media coverage:

• “Giving 12 to 17-year-olds two doses of Pfizer’s Covid vaccine could prevent 4,000 hospitalisations and benefits DO outweigh risks, study claims… but experts criticise ‘limited’ findings”. Connor Boyd. Mail Online. 30/09/2021.
• “Pressure grows on UK vaccine advisers to recommend second dose for teens”. Oliver Barnes. Financial Times. 30/09/2021.
• “Give all teens double Covid vaccinations to avoid long Covid, say experts”. Katie Gibbons. The Times. 30/09/2021.
• “New analysis shows benefits of offering two doses of COVID-19 vaccine to children aged 12-17 clearly outweigh risks”. Rosalind Dewar. Media Office, Royal Society of Medicine. 30/09/2021.
• “Why are government experts holding off vaccinating under-16s in the UK?". Deepti Gurdasani. Guardian. 06/08/2021.
• “Covid-19: All 16 and 17 year olds in the UK to be offered first vaccine dose”. Elisabeth Mahase. BMJ. 05/08/2021.
• “Covid-19 vaccine programme should extend to 12-year-olds to reduce virus spread, scientists say”. Paul Gallagher. The i. 05/08/2021.
• “Group of scientists criticise No10 for ‘unacceptable’ delay in vaccinating children against Covid and say decision to give ALL 16-17 year olds jabs is ‘too little, too late’…. as they question why over-12s won’t get inoculated at the same time”. Luke Andrews. Daily Mail. 04/08/2021.
• “Covid vaccines to be offered to all UK 16- and 17-year-olds”. Jessica Elgot, Natalie Grover and Rowena Mason. Guardian. 04/08/2021.